The cell surface marker detection market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for cell surface marker detection has seen robust growth. There is anticipated growth from $5.91 billion in 2024 to $6.44 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to growth in the previous period include the enlargement in biomedical research, the development of high-content screening, a rise in chronic disease prevalence, and a shift in focus towards immunotherapy.
The Cell Surface Marker Detection market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of detecting cell surface markers is anticipated to experience a swift growth in the forthcoming years. By 2029, this market is predicted to reach $9.9 billion, with a compound annual growth rate (CAGR) of 11.3%.
This predicted growth during the forecast period is a result of several factors such as, the market's expansion in emerging economies, the growth of the biopharmaceutical sector, the acceptance of single-cell analysis, the increase in chronic and infectious diseases, and the escalating funds for life sciences research. Key trends for the forecast period encompass pushes in biotechnology, new product developments, innovative technology in flow cytometry, and a rising prevalence of chronic illnesses.
The escalating prevalence of oncology diseases is projected to drive the expansion of the cell surface marker detection market. Cancer, a disease where certain cells proliferate uncontrollably and infiltrate other parts of the body, propels this growth. The ascent in global cancer cases can be attributed to factors such as the adoption of western lifestyle habits, inadequate diets, frequent consumption of non-vegetarian food, exposure to chemical pollution, and insufficient exercise. Cell surface marker detection aids in the point-of-care prediction of a patient's response to various cancer drugs, thereby boosting their demand. For example, in October 2022, the Macmillan Cancer Support organization, the UK's biggest healthcare charity, postulated that 3 million individuals had cancer in 2020. This estimation is expected to escalate to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the mounting incidence of oncology diseases is a key driver for the growth of the cell surface marker detection market.
The cell surface marker detection market covered in this report is segmented –
1) By Product: Flow Cytometry, Hematology Analyzers, Reagents And Kits
2) By Application: Disease Diagnosis, Diseases Identification, Research For Drug Discovery, Cytological Academic Research
3) By End-Users: Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Testing Laboratories, Academic And Research Institutes, Other End Users
Subsegments:
1) By Flow Cytometry: Benchtop Flow Cytometers, Portable Flow Cytometers, High-Throughput Flow Cytometers
2) By Hematology Analyzers: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers, Point-Of-Care Hematology Analyzers
3) By Reagents And Kits: Antibodies And Conjugates, Staining Kits, Calibration And Control Kits
Top firms in the cell surface marker detection market, such as Bio-Rad Laboratories, Inc., are heavily investing in cutting-edge technologies, such as innovative fluorescent dyes and antibodies. These advancements are aimed at improving multicolour flow cytometry capabilities, crucial for boosting accuracy and efficiency in immunological research and diagnostics. As part of its technological advancement, Bio-Rad broadened its StarBright Violet Dye series by introducing 29 intensively verified antibodies conjugated to various StarBright Violet Dyes. This augmentation significantly amplifies the ability to detect and analyze multiple cell surface markers in human and animal investigations through multicolour flow cytometry. In May 2024, Bio-Rad Laboratories, Inc., a firm based in the USA that specializes in the creation and production of specialized technological products, unveiled three new StarBright Red Dyes- StarBright Red 715, 775, and 815. This development augments their existing series of fluorescent dyes, which now consist of 32 options across multiple lasers, explicitly crafted for conventional and full-spectrum flow cytometry applications. Moreover, compared to traditional cyanine tandem dyes, these dyes display minimal background interference and can be fixed in formalin or alcohol-based fixatives without signal integrity loss.
Major companies operating in the cell surface marker detection market include:
• Thermo Fisher Scientific Inc.
• Beckman Coulter Inc.
• Siemens Healthineers
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Sartorius
• Becton Dickinson and Company
• BD Biosciences
• Grifols SA
• Applied Microarrays Inc.
• R&D Systems
• Agilent Inc.
• Sigma-Aldrich
• Qiagen NV
• Sysmex Corporation
• Nihon Kohden Corporation
• Abnova Corporation
• Diasorin SpA
• Janssen Diagnostics
• Abcam PLC
• GenScript Biotech
• BioLegend
• Cell Signaling Technology Inc.
• Merck KGaA
• Bio-Techne Corporation
• Affymetrix
• Danaher Corporation
• Zymo Research Corporation
• Miltenyi Biotec
North America was the largest region in the cell surface marker detection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.